Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | RGD Reference | Notes | Source | Original Reference(s) | ZNF613 | Human | arsane | multiple interactions | EXP | | 6480464 | [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ZNF613 more ... | CTD | PMID:39836092 | ZNF613 | Human | arsenic atom | multiple interactions | EXP | | 6480464 | [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ZNF613 more ... | CTD | PMID:39836092 | ZNF613 | Human | bortezomib | multiple interactions | EXP | | 6480464 | [BRCA1 mutant form results in increased susceptibility to Bortezomib] which results in increased expression of more ... | CTD | PMID:25522274 | ZNF613 | Human | CGP 52608 | multiple interactions | EXP | | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to ZNF613 gene] | CTD | PMID:28238834 | ZNF613 | Human | copper(II) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of ZNF613 mRNA | CTD | PMID:19549813 | ZNF613 | Human | GSK-J4 | decreases expression | EXP | | 6480464 | GSK-J4 results in decreased expression of ZNF613 mRNA | CTD | PMID:29301935 | ZNF613 | Human | iron dichloride | decreases expression | EXP | | 6480464 | ferrous chloride results in decreased expression of ZNF613 mRNA | CTD | PMID:35984750 | ZNF613 | Human | propanal | increases expression | EXP | | 6480464 | propionaldehyde results in increased expression of ZNF613 mRNA | CTD | PMID:26079696 | ZNF613 | Human | sodium arsenite | multiple interactions | EXP | | 6480464 | [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ZNF613 more ... | CTD | PMID:39836092 | ZNF613 | Human | temozolomide | increases expression | EXP | | 6480464 | Temozolomide results in increased expression of ZNF613 mRNA | CTD | PMID:31758290 | ZNF613 | Human | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of ZNF613 mRNA | CTD | PMID:28001369 | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






















